|  | Experimental groups | ||
---|---|---|---|---|
Parameters | Time, daysa | Sham (n = 11) | cp-MSCs (n = 11) | Placebo (n = 8) |
Ejection fraction, % | -22 | 57.5 ± 3.6 | 59.5 ± 5.6 | 59.3 ± 3.6 |
-1 | 50.2 ± 1.7 | 28.7 ± 2.1b | 27.4 ± 2.6b | |
7 | 49.8 ± 2.4 | 34.3 ± 3.1 | 26.4 ± 3.0 | |
15 | 50.9 ± 2.6 | 33.8 ± 1.9 | 22.9 ± 2.4c | |
23 | 48.3 ± 1.8 | 31.2 ± 3.1 | 24.6 ± 2.6 | |
39 | 46.2 ± 2.6 | 33.8 ± 2.3 | 22.2 ± 2.1d | |
End-systolic volume, μL | -22 | 24.4 ± 3.9 | 23.3 ± 7.4 | 17.7 ± 3.8 |
-1 | 31.3 ± 2.3 | 61.4 ± 4.7b | 67.2 ± 5.5b | |
7 | 31.6 ± 2.7 | 55.5 ± 6.2 | 62.4 ± 7.3 | |
15 | 34.35 ± 3.4 | 60.4 ± 5.3 | 75.8 ± 6.8c | |
23 | 34.5 ± 2.2 | 64.6 ± 6.5 | 77.2 ± 6.4 | |
39 | 34.7 ± 3.5 | 58.3 ± 7.9 | 80.7 ± 8.5c | |
End-diastolic volume, μL | -22 | 56.3 ± 4,9 | 54.8 ± 9.5 | 53.8 ± 8.5 |
-1 | 62.3 ± 3.4 | 84.2 ± 4.3b | 92.0 ± 4.8b | |
7 | 62.6 ± 4.2 | 82.5 ± 5.6 | 90.9 ± 7.9 | |
15 | 68.6 ± 4.2 | 90.6 ± 6.9 | 98.0 ± 6.9 | |
23 | 67.2 ± 3.9 | 91.8 ± 6.1 | 102.6 ± 7.3 | |
39 | 63.6 ± 4.2 | 89.9 ± 9.2 | 104.3 ± 9.6 |